Alpha Cubed Investments, LLC Cns Pharmaceuticals, Inc. Transaction History

Alpha Cubed Investments, LLC

  • $2.24 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022
SELL
$0.26 - $1.05 $260 - $1,050
-1,000 Reduced 9.09%
10,000 $3,000
Q1 2021

Apr 23, 2021
BUY
$1.72 - $4.18 $1,720 - $4,180
1,000 Added 10.0%
11,000 $26,000
Q1 2020

Apr 10, 2020
BUY
$1.45 - $4.99 $14,500 - $49,900
10,000 New
10,000 $21,000

Others Institutions Holding CNSP

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About CNS Pharmaceuticals, Inc.

CNSP Quotes by TradingView
  • Ticker CNSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,032,500
  • Market Cap $4.4M
  • Description
  • CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....
More about CNSP
Track This Portfolio

Track Alpha Cubed Investments, LLC Portfolio

Follow Alpha Cubed Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Cubed Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Cubed Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email